Expansion of lung Vα14 NKT cells by administration of α-galactosylceramidepulsed dendritic cells

Japanese Journal of Cancer Research

Volumn 93, Issue 4, 2002, Pages 397-403

  Akutsu, Yasunori ^a,c   Nakayama, Toshinori ^a,c   Harada, Michishige ^a,c   Kawano, Tetsu ^a,c   Motohashi, Shinichiro ^a,c   Shimizu, Eiko ^a,c   Ito, Toshihiro ^a,c   Kamada, Noriaki ^a,c   Saito, Takeshi ^c   Matsubara, Hisahiro ^c   Miyazawa, Yukimasa ^c   Ochiai, Takenori ^c   Taniguchi, Masaru ^a,b  

^a JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^b RIKEN Center for Integrative Medical Sciences   (Japan)

^c CHIBA UNIVERSITY   (Japan)

Author keywords

Dendritic cell; NKT cell; Galactosylceramide

Indexed keywords

CD1 ANTIGEN; GALACTOSYLCERAMIDE; GLYCOLIPID; LIGAND; T LYMPHOCYTE RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER IMMUNOTHERAPY; CELL ACTIVATION; CELL ACTIVITY; CELL SPECIFICITY; CONTROLLED STUDY; DENDRITIC CELL; DRUG PULSE THERAPY; FEASIBILITY STUDY; GENETIC CODE; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE RECEPTOR GENE; TUMOR CELL LINE;

ANIMALS; ANTIGENS, CD1; ANTINEOPLASTIC AGENTS; CELL CULTURE TECHNIQUES; CELL LINE, TUMOR; CELL LINEAGE; CELLS, CULTURED; CHROMIUM RADIOISOTOPES; DENDRITIC CELLS; GALACTOSYLCERAMIDES; IMMUNOTHERAPY; LEUKOCYTES, MONONUCLEAR; LIGANDS; LUNG; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; NEOPLASM METASTASIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA;

EID: 18344365580     PISSN: 09105050     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2002.tb01270.x     Document Type: Article

References (37)

1. Recognition and function of Vα14 NKT cells
2. + T-cell antigen receptor α chain expanded in unprimed mice
3. - T cells in mice and humans
4. + T cell populations
5. Activation of natural killer T cells by α-galactosylceramide treatment prevents the onset and recurrence of autoimmune Type 1 diabetes
6. The natural killer T-cell ligand α-galactosylceramide prevents autoimmune diabetes in non-obese diabetic mice
7. CD1d-restricted and TCR-mediated activation of vα14 NKT cells by glycosylceramides
8. + NK T lymphocytes
9. Antigen-presenting function of mouse CD1: One molecule with two different kinds of antigenic ligands
10. Natural killer-like nonspecific tumor cell lysis mediated by specific ligand-activated Vα14 NKT cells
11. Inhibition of tumor metastasis by adoptive transfer of IL-12-activated Vα14 NKT cells
12. Differential tumor surveillance by natural killer (NK) and NKT cells
13. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) contributes to interferon γ-dependent natural killer cell protection from tumor metastasis
14. Augmentation of Vα14 NKT cell-mediated cytotoxicity by interleukin 4 in an autocrine mechanism resulting in the development of concanavalin A-induced hepatitis
15. Antitumor cytotoxicity mediated by ligand-activated human Vα24 NKT cells
16. Cutting edge: Inhibition of experimental tumor metastasis by dendritic cells pulsed with α-galactosylceramide
17. RAG-1-deficient mice have no mature B and T lymphocytes
18. The cell surface of mouse dendritic cells: FACS analyses of dendritic cells from different tissues including thymus
19. Dendritic cells as the terminal stage of monocyte differentiation
20. Proliferating dendritic cell progenitors in human blood
21. Expression of the common cytokine receptor gamma chain by murine dendritic cells including epidermal Langerhans cells
22. Improved FACS analysis confirms generation of immature dendritic cells in long-term stromal-dependent spleen cultures
23. Intermediate TCR cells in mouse lung: Their effector function to induce pneumonitis in mice with autoimmune-like graft-versus-host disease
24. Tracking the response of natural killer T cells to a glycolipid antigen using CD1d tetramers
25. Antitumor activity of α-galactosylceramide, KRN7000, in mice with EL-4 hepatic metastasis and its cytokine production
26. Antitumor activity of α-galactosylceramide, KRN7000, in mice with the melanoma B16 hepatic metastasis and immunohistological study of tumor infiltrating cells
27. The anti-tumor activity of IL-12: Mechanisms of innate immunity that are model and dose dependent
28. Selective expansion and partial activation of human NK cells and NK receptor-positive T cells by IL-2 and IL-2 and IL-15
29. Adoptive immunotherapy of established pulmonary metastases with LAK cells and recombinant interleukin-2
30. Adoptive immunotherapy for head and neck cancer with killer cells induced by stimulation with autologous or allogeneic tumor cells and recombinant interleukin-2
31. Adoptive cellular immunotherapy for the treatment of malignant gliomas
32. NK cells are essential for effective BCG immunotherapy
33. CD1d-mediated recognition of an α-galactosylceramide by natural killer T cells is highly conserved through mammalian evolution
34. CD1d-restricted recognition of synthetic glycolipid antigens by human natural killer T cells
35. A novel recognition motif of human NKT antigen receptor for a glycolipid ligand
36. Dynamic micro-magnetic resonance imaging of liver micrometastasis in mice with a novel liver macromolecular magnetic resonance contrast agent DAB-Am64-(1B4M-Gd)(64)
37. Real-time observation of micrometastasis formation in the living mouse liver using a green fluorescent protein gene-tagged rat tongue carcinoma cell line